Table 2.
Outcome measurements during the entire study.
Outcome Measure | CM(n=69) | SM(n=69) | Mean Difference | P Value |
---|---|---|---|---|
(95% CI) | ||||
Baseline | ||||
| ||||
WOMAC subscale score | ||||
Pain | 7.4(3.4) | 7.6(2.9) | -0.2(-1.3 to1) | 0.81 |
Stiffness | 1.6(1.6) | 1.6(1.6) | 0(-0.6 to 0.6) | 0.98 |
Function | 25.2(11.8) | 22.9(12.7) | 2.3(-2.0 to 6.7) | 0.29 |
| ||||
VAS score | 4.1(1.4) | 4.0(1.4) | 0.1(-0.4 to 0.6) | 0.62 |
| ||||
2 week | ||||
| ||||
WOMAC subscale score | ||||
Pain | 5.8(3.7) | 6.2(3.1) | -0.4(-1.6 to 0.8) | 0.53 |
Stiffness | 1.2(1.5) | 1.3(1.4) | -0.1(-0.5 to 0.5) | 0.94 |
Function | 18.9(11.3) | 18.0(11.1) | 0.9(-3.0 to 5.0) | 0.63 |
| ||||
VAS score | 3.0(1.4) | 3.1(1.5) | -0.1(-0.6 to 0.4 ) | 0.61 |
| ||||
4 week | ||||
| ||||
WOMAC subscale score | ||||
Pain | 4.1(3.0) | 4.2(2.9) | -0.1(-1.2 to 0.9) | 0.76 |
Stiffness | 0.7(1.2) | 0.8(1.1) | -0.1(-0.5 to 0.3 ) | 0.71 |
Function | 15.1(10.8) | 12.9(9.2) | 2.2(-1.3 to 5.8) | 0.22 |
| ||||
VAS score | 2.2(1.3) | 2.1(1.3) | 0.1(-0.3 to 0.6) | 0.60 |
| ||||
8 week | ||||
| ||||
WOMAC subscale score | ||||
Pain | 4.1(3.1) | 4.2(3.0) | -0.1(-1.2 to 0.1) | 0.81 |
Stiffness | 0.7(1.2) | 0.6(1.0) | 0.1(-0.3 to 0.4) | 0.79 |
Function | 15.1(10.8) | 12.7(8.9) | 2.4(-1.1 to 5.9) | 0.18 |
| ||||
VAS score | 2.2(1.2) | 2.1(1.2) | 0.1(-0.3 to 0.6) | 0.62 |
| ||||
12 week | ||||
| ||||
WOMAC subscale score | ||||
Pain | 4.1(3.2) | 4.0(2.8) | 0.1(-1.0 to 1.2) | 0.86 |
Stiffness | 0.7(1.3) | 0.6(1.0) | 0.1(-0.3 to 0.5) | 0.73 |
Function | 15.6(10.6) | 12.4(9.3) | 3.2(-0.2 to 6.9) | 0.06 |
| ||||
VAS score | 2.1(1.2) | 2.1(1.2) | 0(-0.4 to 0.5) | 0.83 |
Abbreviations: SM, Smoke-Free Moxibustion; CM, Conventional Moxibustion; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index; VAS, Visual Analog Scale.
CM and SM group data are expressed as mean (SD) unless stated otherwise.